These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31557402)

  • 1. ALPK1 regulates streptozotocin-induced nephropathy through CCL2 and CCL5 expressions.
    Lee CP; Nithiyanantham S; Hsu HT; Yeh KT; Kuo TM; Ko YC
    J Cell Mol Med; 2019 Nov; 23(11):7699-7708. PubMed ID: 31557402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the chemokines MCP-1/CCL2 and RANTES/CCL5 is differentially regulated by infiltrating inflammatory cells.
    Haberstroh U; Pocock J; Gómez-Guerrero C; Helmchen U; Hamann A; Gutierrez-Ramos JC; Stahl RA; Thaiss F
    Kidney Int; 2002 Oct; 62(4):1264-76. PubMed ID: 12234296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy.
    Mezzano S; Aros C; Droguett A; Burgos ME; Ardiles L; Flores C; Schneider H; Ruiz-Ortega M; Egido J
    Nephrol Dial Transplant; 2004 Oct; 19(10):2505-12. PubMed ID: 15280531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced alpha-kinase 1 accelerates multiple early nephropathies in streptozotocin-induced hyperglycemic mice.
    Kuo TM; Hsu HT; Chung CM; Yeh KT; Wu CT; Lee CP; Chiang SL; Huang CM; Ko YC
    Biochim Biophys Acta; 2016 Nov; 1862(11):2034-2042. PubMed ID: 27542954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.
    Raghu H; Lepus CM; Wang Q; Wong HH; Lingampalli N; Oliviero F; Punzi L; Giori NJ; Goodman SB; Chu CR; Sokolove JB; Robinson WH
    Ann Rheum Dis; 2017 May; 76(5):914-922. PubMed ID: 27965260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous NAMPT dampens chemokine expression and apoptotic responses in stressed tubular cells.
    Benito-Martin A; Ucero AC; Izquierdo MC; Santamaria B; Picatoste B; Carrasco S; Lorenzo O; Ruiz-Ortega M; Egido J; Ortiz A
    Biochim Biophys Acta; 2014 Feb; 1842(2):293-303. PubMed ID: 24287278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-C Motif Chemokine 5 Attenuates Angiotensin II-Dependent Kidney Injury by Limiting Renal Macrophage Infiltration.
    Rudemiller NP; Patel MB; Zhang JD; Jeffs AD; Karlovich NS; Griffiths R; Kan MJ; Buckley AF; Gunn MD; Crowley SD
    Am J Pathol; 2016 Nov; 186(11):2846-2856. PubMed ID: 27640148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
    Lin M; Yiu WH; Li RX; Wu HJ; Wong DW; Chan LY; Leung JC; Lai KN; Tang SC
    Kidney Int; 2013 May; 83(5):887-900. PubMed ID: 23423259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine MCP1/CCL2 and RANTES/CCL5 gene polymorphisms influence Henoch-Schönlein purpura susceptibility and severity.
    Yu HH; Liu PH; Yang YH; Lee JH; Wang LC; Chen WJ; Chiang BL
    J Formos Med Assoc; 2015 Apr; 114(4):347-52. PubMed ID: 25839768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate signaling mechanisms controlling Mycobacterium chelonae-mediated CCL2 and CCL5 expression in macrophages.
    Kim YS; Kim JH; Woo M; Kim TS; Sohn KM; Lee YH; Jo EK; Yuk JM
    J Microbiol; 2015 Dec; 53(12):864-74. PubMed ID: 26626357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo.
    Bursill CA; Castro ML; Beattie DT; Nakhla S; van der Vorst E; Heather AK; Barter PJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1773-8. PubMed ID: 20702809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ashwagandha attenuates TNF-α- and LPS-induced NF-κB activation and CCL2 and CCL5 gene expression in NRK-52E cells.
    Grunz-Borgmann E; Mossine V; Fritsche K; Parrish AR
    BMC Complement Altern Med; 2015 Dec; 15():434. PubMed ID: 26667305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of retinoic acid in experimental diabetic nephropathy.
    Han SY; So GA; Jee YH; Han KH; Kang YS; Kim HK; Kang SW; Han DS; Han JY; Cha DR
    Immunol Cell Biol; 2004 Dec; 82(6):568-76. PubMed ID: 15550114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive effects of antimycotics on tumor necrosis factor-alpha-induced CCL27, CCL2, and CCL5 production in human keratinocytes.
    Kanda N; Watanabe S
    Biochem Pharmacol; 2006 Aug; 72(4):463-73. PubMed ID: 16784723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL2 conditionally determines CCL22-dependent Th2-accumulation during TGF-β-induced breast cancer progression.
    Mandal PK; Biswas S; Mandal G; Purohit S; Gupta A; Majumdar Giri A; Roy Chowdhury S; Bhattacharyya A
    Immunobiology; 2018 Feb; 223(2):151-161. PubMed ID: 29107385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice.
    El-Hage N; Bruce-Keller AJ; Knapp PE; Hauser KF
    J Neuroimmune Pharmacol; 2008 Dec; 3(4):275-85. PubMed ID: 18815890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant guinea pig CCL5 (RANTES) differentially modulates cytokine production in alveolar and peritoneal macrophages.
    Skwor TA; Cho H; Cassidy C; Yoshimura T; McMurray DN
    J Leukoc Biol; 2004 Dec; 76(6):1229-39. PubMed ID: 15377675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALPK1 affects testosterone mediated regulation of proinflammatory cytokines production.
    Kuo TM; Yeh KT; Hsu HT; Chiang SL; Chang JG; Huang CM; Tu HP; Liu CS; Ko YC
    J Steroid Biochem Mol Biol; 2015 Nov; 154():150-8. PubMed ID: 26275947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of NF-kappaB-dependent proinflammatory gene expression in human RPE cells by a proteasome inhibitor.
    Wang XC; Jobin C; Allen JB; Roberts WL; Jaffe GJ
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):477-86. PubMed ID: 9950608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-33 stimulates human mast cell release of CCL5 and CCL2 via MAPK and NF-κB, inhibited by methoxyluteolin.
    Bawazeer MA; Theoharides TC
    Eur J Pharmacol; 2019 Dec; 865():172760. PubMed ID: 31669588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.